Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Working Capital Changes: 2009-2025

Historic Other Working Capital Changes for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to -$67.2 million.

  • UNITED THERAPEUTICS's Other Working Capital Changes fell 58.49% to -$67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year decrease of 66.89%. This contributed to the annual value of $55.6 million for FY2024, which is 32.85% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Other Working Capital Changes of -$67.2 million as of Q3 2025, which was down 136.44% from $184.4 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Other Working Capital Changes registered a high of $184.4 million during Q2 2025, and its lowest value of -$134.5 million during Q1 2025.
  • For the 3-year period, UNITED THERAPEUTICS's Other Working Capital Changes averaged around $11.0 million, with its median value being $4.3 million (2023).
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Other Working Capital Changes spiked by 648.41% in 2022, and later tumbled by 1,086.05% in 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Other Working Capital Changes (Quarterly) stood at $12.6 million in 2021, then soared by 648.41% to $94.3 million in 2022, then tumbled by 56.20% to $41.3 million in 2023, then declined by 10.17% to $37.1 million in 2024, then plummeted by 58.49% to -$67.2 million in 2025.
  • Its Other Working Capital Changes stands at -$67.2 million for Q3 2025, versus $184.4 million for Q2 2025 and -$134.5 million for Q1 2025.